[KROS] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -10.16%
YoY- -35.36%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
Revenue 83 0 0 0 2,500 2,500 -49.35%
PBT -43,114 -35,804 -24,186 -15,835 -12,064 -3,183 68.30%
Tax -277 -3,065 1 50 -172 2 -
NP -43,114 -32,739 -24,187 -15,885 -11,892 -3,183 68.30%
Tax Rate - - - - - - -
Total Cost 43,197 32,739 24,187 15,885 14,392 5,683 49.96%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
NP Margin -51,944.58 0.00 0.00 0.00 -475.68 -127.32 232.32%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
EPS -1.46 -1.15 -1.01 -0.68 -0.65 -0.36 32.27%
EPS Diluted -1.46 -1.15 -1.01 -0.68 -0.65 -0.36 32.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.